The breast seldom harbors secondary malignant lesions and is rarer for the kidney to be the origin of the metastatic lesion. Keen Imaging analysis, as well as a high index of suspicion, are critical to differentiate a primary tumor from a metastatic lesion. We describe an unusual case of a recurrent RCC presenting as metastatic lesions to the breast and soft tissue of the right thigh in a 51-year-old patient referred to our breast-imaging unit 10 months after therapeutic surgery.
View Article and Find Full Text PDFActa Radiol
November 2020
Background: It has been demonstrated that the number of metastatic axillary lymph nodes (mALNs) influence disease-free and overall survival in patients with breast cancer.
Purpose: To determine if the ALN size is more accurate than the ALN apparent diffusion coefficient (ADC) value to predict metastatic involvement in newly diagnosed breast cancer.
Material And Methods: A total of 44 patients with breast cancer were included.
Rationale And Objectives: This study explored tumor behavior in patients with breast cancer during neoadjuvant chemotherapy (NAC) by sequential measurements of tumor apparent diffusion coefficient (ADC) after each chemotherapy cycle. The aim was to determine if the tumor ADC is useful to differentiate complete pathological response (cPR) from partial pathological response (pPR) during NAC.
Materials And Methods: A total of 16 cases (in 14 patients) with diagnosis of breast cancer eligible to receive NAC were included.
Diffusion-weighted imaging and apparent diffusion coefficient (ADC) of 36 breast lesions previously categorized as 4 according to the Breast Imaging Reporting and Data System (BI-RADS) were prospectively studied. The pathological results were 21 benign lesions and 15 malignant. The ADC of malignant lesions was significantly lower than that of the benign ones (0.
View Article and Find Full Text PDF